Table 1 The frequency of neurological manifestations in patients with COVID-19
Variable | Number | percent | |
|---|---|---|---|
Age (16–69 years) | Mean | 43.27 | |
Std. deviation | 13.998 | ||
Gender | Male | 39 | 55.7 |
Female | 31 | 44.3 | |
Neurologic symptoms* | Headache | 56 | 80 |
Anosmia/hypogeusia | 44 | 62.9 | |
Stroke symptoms | 32 | 45.7 | |
Disturbed consciousness | 20 | 28.6 | |
Seizers | 5 | 7.1 | |
Extra-pyramidal (Parkinson like) | 1 | 1.4 | |
Neuropsychiatric symptoms | No neuropsychiatric symptoms | 43 | 61.4 |
Low mood and anxiety | 12 | 17.1 | |
Prolonged fatigue | 10 | 14.3 | |
Depression | 5 | 7.1 | |
Serious non neurologic association | C/P: Edema around eye | 1 | 1.4 |
MRI: Fungal sinusitis | |||
Outcome | Survivors | 47 | 67.1 |
Death | 12 | 17.1 | |
Unclear | 11 | 15.7 |